期刊文献+

急性髓系白血病预后相关的分子标志 被引量:3

Molecular Markers Related to Prognosis of Acute Myeloid leukemia——Review
下载PDF
导出
摘要 众多的无法被细胞遗传学方法检测出来的基因异常(如基因突变及表达异常等)已越来越多的被发现。这使得对不同预后的急性髓系白血病(acute myeloid leukemia,AML)的分析进入分子水平。例如:存在转录因子C/EBPα(CCAAT enhancer binding factoralpha,CCAAT增强结合因子α亚单位)或核磷蛋白(nucleophosmin-1,NPM)基因突变的AML往往提示有较好的预后,而有着MLL基因(mixed-lineage leukemia,混合系白血病基因)部分串联重复突变(MLL-PTD),FLT3(FLM样酪氨酸激酶3)基因串联重复突变(FLT3-ITD)以及WT-1(Wilms′Tumor1,肾母细胞瘤1)基因突变的AML却提示不良预后。本文将探讨这些异常基因分子的特点,联系及其对AML预后的影响。 Numerous genetic abnormalities which can not be identified by cytogenetic detection (e. g., gene mutations, gene expression abnormalities ) have been gradually found, which means that the further molecular classification of AML (acute myeloid leukemia) with distinctive prognosis have arrived. For example, mutations of the transcription factor (CCAAT enhancer binding factor alpha, prognosis, whereas partial tandem duplications of the MLL C/EBPα) or nucleophosmin-1 (NPM1) may predict better gene (MLL-PTD), internal tandem duplications of FLT3 (FLT3-ITD) or mutations of WT1 gene confer worse prognosis. This review focuses on the features and relationship of these genetic abnormalities, as well as their influence on the prognosis of AML.
出处 《中国实验血液学杂志》 CAS CSCD 2009年第4期1083-1087,共5页 Journal of Experimental Hematology
关键词 急性髓系白血病 分子标志 EVI-1 ERG BAALC MNI WTI NPMI C—Kit MLL—PTD FLT3 CCAAT GATA-2 acute myeloid leukemia molecular Mark EVI-1 ERG BAALC MNI WTI NPMI C-Kit MLL-PTD FLT3 CCAAT GATA-2
  • 相关文献

参考文献24

  • 1Haas K, Kundi M, Sperr WR, et al. Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVIl in 266 patients with de novo AML: EVIl and MDS1/EVI1 overexpression both predict short remission duration. Genes Chromosomes Cancer,2008 ;47:288 - 298.
  • 2Lugthart S, Van Drunen E, Van Norden Y, et al. High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVIl over-expression and chromosome 3q26 abnormalities underestimated. Blood,2008 ; 111:4329 -4337.
  • 3Marcucci G, Baldus CD, Ruppert AS, et al. Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study. J Clin Oncol,2005 ;23:9234 -9242.
  • 4Marcucci G, Maharry K, Whitman SP, et al. High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study. J Clin Oncol, 2007 ;25:3337 - 3343.
  • 5李红艺,魏旭东,吕晓东,岳寒,范瑞华,徐本玲,郭金东,胡杰英,房佰俊,宋永平.实时荧光定量PCR检测BAALC基因在正常核型急性髓系白血病中的表达[J].中国现代医学杂志,2008,18(12):1706-1709. 被引量:6
  • 6Baldus CD, Thiede C, Soucek S, et al. BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications. J Clin Oncol, 2006 ;24:790 - 797.
  • 7Langer C, Radmacher MD, Ruppert AS, et al. High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B ( CALGB ) study. Blood, 2008 ; 111:5371 -5379.
  • 8Heuser M, Beutel G, Krauter J, et al. High meningioma 1 (MN1) expres- sion as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. Blood, 2006; 108: 3898- 905.
  • 9Carella C, Bonten J, Sirma S, et al. MN1 overexpression is an important step in the development of inv ( 16 ) AML. Leukemia, 2007 ;21 : 1679 - 1690.
  • 10Heuser M, Argiropoulos B, Kuchenbauer F, et al. MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in AML patients. Blood ,2007 ; 110 : 1639 - 1647.

二级参考文献28

  • 1陈赛娟,陈丽娟,周光飚.白血病基因产物靶向治疗的基础和临床研究[J].中国实验血液学杂志,2005,13(1):1-8. 被引量:12
  • 2汪亚伦,王彤,许凤,冮岩,王杰.伴有6;9染色体易位急性髓系白血病患者DEK-CAN融合基因表达分析[J].中国实验血液学杂志,2006,14(2):232-236. 被引量:8
  • 3汪亚伦,王彤,许凤,冮岩,王杰.急性髓系白血病细胞Flt-3表达及Flt-3/ITD突变分析[J].中国实验血液学杂志,2006,14(3):446-449. 被引量:6
  • 4王杰,王彤,李树,林莉,冮岩.儿童白血病患者Flt-3/ITD突变分析及其临床意义[J].癌症,2007,26(1):58-63. 被引量:5
  • 5Stirewalt DL,Radich JP.The role of FLT3 in haematopoietic malignancies.Nat Rev Cancer,2003; 3:650 -665
  • 6Steudel C,Wermke M,Schaich M,et al.Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.Genes Chromosomes Cancer,2003; 37:237 -251
  • 7Mrozek K,Tanner SM,Heinonen K,et al.Molecular cytogenetic characterization of the KG-1 and KG-1a acute myeloid leukemia cell lines by use of spectral karyotyping and fluorescence in situ hybridization.Genes Chromosomes Cancer,2003; 38:249-252
  • 8Kiyoi H,Yanada M,Ozekia K.Clinical significance of FLT3 in leukemia.Int J Hematol,2005; 82:85 -92
  • 9Yang X,Liu L,Sternberg D,et al.The FLT3 Internal tandem duplication mutation prevents apoptosis in interleukin-3-deprived BaF3 cells due to protein kinase A and ribosomal S6 kinase 1-mediated BAD phosphorylation at serine 112.Cancer Res,2005; 65:7338 -7347
  • 10Zheng R,Friedman AD,Levis M,et al.Internal tandem duplication mutation of FLT3 blocks myeloid differentiation through suppression of C/EBPα expression.Blood,2004; 103:1883-1890

共引文献9

同被引文献28

  • 1卢瑞南,李建勇.Fms样酪氨酸激酶3突变与恶性血液病[J].中华内科杂志,2005,44(2):157-158. 被引量:1
  • 2陈赛娟,曹琪,马志贵,苏欣莹,熊树民,叶菁,王振义,李秀松,沈志祥,张芬琴,孙关林,方智雯,欧阳仁荣,朱学宏,应大明,顾龙君,陈竺.急性非淋巴细胞白血病的细胞遗传学及其预后意义[J].中华血液学杂志,1996,17(2):61-63. 被引量:27
  • 3王小钦,林果为.282例原发性骨髓增生异常综合征诊断和分型的前瞻性临床研究[J].中华血液学杂志,2006,27(8):546-549. 被引量:34
  • 4Grimwade D, Hills RK, Moorman AV, et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood, 2010, 116 : 354-365.
  • 5S|ovak ML, Kopecky KJ, Cassileth PA, et al. Karyotype analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study. Blood, 2000, 96: 4075- 4083.
  • 6Grimwade D, Walker H, Harrison G, et al. The predictive valueof hierachical cytogenetic classification in older adults with acute myeloid leukemia (AML) : analysis of 1065 patients entered into the United Kingdom Medical Research Council AML 11 trial. Blood, 2001, 98: 1312-1320.
  • 7Jaffe ES, Harris NL, Stein H, et al. World Health Organization Classification of Tumours. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001 : 75-115.
  • 8Shaffer LG, Tommerup N. ISCN (2005). An International System for Human Cytogenetic Nomenclature. Switzerland: Karger Baselpublication, 2005 : 55-83.
  • 9Breems DA, Van Putten WL, De Greef GE, et al. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. J Clin Oncol, 2008, 26: 4791-4797.
  • 10Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic eytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood, 1998, 92: 2322-2333.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部